Product Images Spironolactone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Spironolactone NDC 70518-2386 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Spironolactone is a medication that comes in a quantity of 100 HD2 and is available only with a prescription. The NDC (National Drug Code) for this medication is 70518-2386-00 and is manufactured by Zydus Pharmaceuticals located in Pennington, NJ. The Lot number and expiration date are not available. The packaging company for the medication is RemedyRepack Inc. located in Indiana, PA. It is recommended to keep this medication out of the reach of children and to store it between 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F) as per USP standards. Directions for use can be found in the package insert.*

MM5 - Spironolactone 50mg 70518 2386 01

MM5 - Spironolactone 50mg 70518 2386 01

Spironolactone is a prescription medicine indicated for various purposes, the details of which can be found in the package insert. The bottle contains one HD2 dosage of spironolactone. The product is available only by prescription and should be kept out of the reach of children. The lot number and the source NDC code of the product are printed on the bottle. The manufacturer of the product is Zydus Pharm located in Pennington, N.J. The medication should be stored between 20-26°C (63-77°F) with excursions permitted between 15-30°C (59-86°F) [See USP]. The RemedyRepack Inc., Indiana, PA 15701, 724.466.8762 has repackaged it.*

Image - b9a028ee 5720 4b9e a625 f7130aafd084 01

Image - b9a028ee 5720 4b9e a625 f7130aafd084 01

Image - b9a028ee 5720 4b9e a625 f7130aafd084 02

Image - b9a028ee 5720 4b9e a625 f7130aafd084 02

The text describes a study with two groups of subjects, one group taking Spironolactone (822 subjects), the other taking a placebo (841 subjects). The study lasted for 42 months and the Log-rank p value was <0.001. No other information is provided.*

Image - b9a028ee 5720 4b9e a625 f7130aafd084 03

Image - b9a028ee 5720 4b9e a625 f7130aafd084 03

This appears to be a table showing subgroups and various parameters for a study on heart failure, including age, sex, race, heart failure severity, presence of diabetes, creatinine levels, drugs used and their effectiveness in comparison to placebo.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.